Metrion Biosciences Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Metrion Biosciences Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11099
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Metrion Biosciences Ltd (Metrion Biosciences) is a contract research organization that offers ion channel drug discovery services. The organization offers cardiac safety screening services, neuroscience-related assays and platforms and translational assays. Its ion channel screening services include compound screening, cell line optimization, assay development and ion channel library. Metrion Biosciences’s holds expertise from assay development, plate-based and HT screening, hit finding and lead optimisation through to preclinical outsourcing. The organization is developing a multi-electrode array (MEA) platform which is capable of making high signal:noise recordings of physiological activity from native neuronal cells such as rodent DRG neurons or brain tissue. Metrion Biosciences is headquartered in Cambridge, the UK.

Metrion Biosciences Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Metrion Biosciences Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Metrion Biosciences Acquires Rights to Small Molecule Potassium Channel Inhibitors from Japan Tobacco 11
Venture Financing 12
Metrion Biosciences to Raise USD0.8 Million in Venture Financing 12
Partnerships 13
Metrion Biosciences Enters into Agreement with LifeArc 13
Metrion Biosciences Enters into Agreement with Concept Life Sciences 14
Peakdale Molecular Partners with Metrion Biosciences 15
Axiogenesis Enters into Agreement with Metrion Biosciences 16
Axol Bioscience and Metrion Biosciences Enter into Research Agreement 17
Metrion Biosciences Ltd – Key Competitors 18
Metrion Biosciences Ltd – Key Employees 19
Metrion Biosciences Ltd – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Corporate Communications 21
Feb 12, 2018: Metrion Biosciences Establishes Scientific Advisory Board 21
May 02, 2017: Metrion Biosciences appoints Chief Operating Officer and Head of Business Development 22
Government and Public Interest 23
Feb 05, 2018: Metrion Biosciences Awarded £200k Funding Under Innovate UK Biomedical Catalyst Feasibility Award 23
Product News 24
08/28/2018: Metrion Biosciences awarded £637k funding under Innovate UK Biomedical Catalyst Primer Award for ion channel drug discovery 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Metrion Biosciences Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Metrion Biosciences Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Metrion Biosciences Acquires Rights to Small Molecule Potassium Channel Inhibitors from Japan Tobacco 11
Metrion Biosciences to Raise USD0.8 Million in Venture Financing 12
Metrion Biosciences Enters into Agreement with LifeArc 13
Metrion Biosciences Enters into Agreement with Concept Life Sciences 14
Peakdale Molecular Partners with Metrion Biosciences 15
Axiogenesis Enters into Agreement with Metrion Biosciences 16
Axol Bioscience and Metrion Biosciences Enter into Research Agreement 17
Metrion Biosciences Ltd, Key Competitors 18
Metrion Biosciences Ltd, Key Employees 19

List of Figures
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Metrion Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Metrion Biosciences Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Metrion Biosciences Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • United Rentals Inc:戦略・SWOT・企業財務分析
    United Rentals Inc - Strategy, SWOT and Corporate Finance Report Summary United Rentals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Barrett Business Services Inc (BBSI):企業の財務・戦略的SWOT分析
    Summary Barrett Business Services Inc (BBSI) is a management consulting company that offers business management solutions. The company’s services include human capital management, preferred payroll, and staffing. Its payroll services handles deductions, liens, tax levies, tax payments, w-2s, and wag …
  • Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349):企業の財務・戦略的SWOT分析
    Summary Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (FDZJ), a subsidiary of Shanghai Pharmaceutical Co Ltd, is a bio-pharmaceutical company that develops, manufactures and markets genetic engineering drugs. The company offers bio-pharmaceutical products in the field of genetic engineering, p …
  • NXP Semiconductors NV (NXPI):企業の財務・戦略的SWOT分析
    NXP Semiconductors NV (NXPI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Resources Connection Inc (RECN):企業の財務・戦略的SWOT分析
    Summary Resources Connection Inc (Resources Connection) operates as a consultancy firm that offers consulting and business initiative support services. The firm offers services such as change management, finance and accounting services, merger and acquisition transaction services, program and projec …
  • Metropolitan Bank & Trust Company (MBT):企業の財務・戦略的SWOT分析
    Metropolitan Bank & Trust Company (MBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • ITOCHU Techno-Solutions Corp (4739):企業の財務・戦略的SWOT分析
    ITOCHU Techno-Solutions Corp (4739) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • SomaLogic Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary SomaLogic Inc (SomaLogic) is a life science company that discovers, develops and commercializes life science research tools and clinical diagnostic products. The company’s products include SOMAscan assay and SOMAmer reagents. Its SOMAscan reagents is a proteomic platform that combines the pr …
  • Oragenics Inc (OGEN)-製薬・医療分野:企業M&A・提携分析
    Summary Oragenics Inc (Oragenics) is a biopharmaceutical company that focuses on the development and commercialization of novel antibiotics against infectious disease and develops treatments for oral mucositis. The company develops a new class of potent gram-positive antibiotics which are called Lan …
  • ConocoPhillips (COP)-エネルギー分野:企業M&A・提携分析
    Summary ConocoPhillips is an independent upstream oil and gas company. The company explore for, produce, transport and market crude oil, bitumen, natural gas, liquefied natural gas (LNG) and natural gas liquids across the world. It has assets across North America, Europe, Asia and Australia. Its ass …
  • NHPC Ltd (NHPC):電力:M&Aディール及び事業提携情報
    Summary NHPC Ltd (NHPC), a Government of India Enterprise, is an energy utility. It plans, promotes and organizes the development of hydro power plants. The company generates electricity using hydro, wind and solar sources. NHPC’s offerings cover the development operations of conventional and non-co …
  • Petro Vista Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Petro Vista Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Petro Vista Energy Corp (Petro Vista) is an oil and gas company that offers oil and gas exploration and development services. The company offers acquisition, development, exploration, and product …
  • Crown Castle International Corp (CCI):企業の財務・戦略的SWOT分析
    Crown Castle International Corp (CCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Ingles Markets Inc:企業の戦略・SWOT・財務情報
    Ingles Markets Inc - Strategy, SWOT and Corporate Finance Report Summary Ingles Markets Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Salling Group AS:企業の戦略的SWOT分析
    Salling Group AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Hebron Technology Co., Ltd. (HEBT):企業の財務・戦略的SWOT分析
    Hebron Technology Co., Ltd. (HEBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • iCAD Inc (ICAD)-医療機器分野:企業M&A・提携分析
    Summary iCAD Inc (iCAD) is a medical device company. It develops and markets computer aided detection (CAD) solutions and workflow solutions for mammography (film-based, digital radiography (DR) and computed radiography (CR), Magnetic Resonance Imaging (MRI), and Computed Tomography (CT). iCAD produ …
  • Banca Popolare di Spoleto S.p.A.:企業の戦略・SWOT・財務情報
    Banca Popolare di Spoleto S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Banca Popolare di Spoleto S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Harel Insurance Investments and Financial Services Ltd:企業のM&A・事業提携・投資動向
    Harel Insurance Investments and Financial Services Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Harel Insurance Investments and Financial Services Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes bus …
  • Andrade Gutierrez SA:企業の戦略的SWOT分析
    Andrade Gutierrez SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆